Sarepta Therapeutics Inc.

In News

Sarepta Therapeutics Announces Second Quarter 2026 Financial Results and Recent Corporate Developments - Sarepta Therapeutics

Sarepta Therapeutics - Aug 05, 2026

Sarepta Therapeutics Presents New Preclinical Data Demonstrating Robust Knockdown of Pathogenic DMPK RNA in the Nucleus with SRP-1003 in DM1 at 2026 Oligonucleotide Therapeutics Society Annual Meeting - Business Wire

Business Wire - Oct 14, 2026

Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? - Stocktwits

Stocktwits - Oct 15, 2026

Sarepta presents 80 percent DM1 data for Sarepta Therapeutics stock - ad-hoc-news.de

ad-hoc-news.de - Oct 18, 2026

Jim Cramer Explains His Hesitation Over Sarepta (SRPT) Therapeutics - Yahoo Finance

Yahoo Finance - Oct 07, 2026

Sarepta Therapeutics Announces Presentations at 2026 World Muscle Society Annual Congress - Sarepta Therapeutics

Sarepta Therapeutics - Sep 25, 2026

Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy - Stocktwits

Stocktwits - Oct 16, 2026

Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

Business Wire - Sep 30, 2026

Sarepta Therapeutics Inc (SRPT) (Q2 2026) Earnings Call Highlights: Strong Profitability and ... - Yahoo Finance

Yahoo Finance - Aug 05, 2026

Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2025 Financial Results and Recent Corporate Developments - Sarepta Therapeutics

Sarepta Therapeutics - Feb 25, 2026

Sarepta Therapeutics to Present New Data from its Neuromuscular Portfolio at 27 - Business Wire

Business Wire - Sep 24, 2026

Sarepta Therapeutics (SRPT) Names A New CEO, Is The Stock Cheap? - Yahoo Finance

Yahoo Finance - Aug 01, 2026

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment